Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BMS is a top global pharmaceutical company with multiple FDA-approved therapies across oncology, cardiovascular, immunology, and more, including blockbuster products such as nivolumab (Opdivo), apixaban (Eliquis), and lenalidomide (Revlimid). Recent clinical additions include approval for new schizophrenia drugs and continued expansion in cancer and cell therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bristol University.